NU SKIN ENTERPRISES INC
For the period ended Dec 31, 2024. Filed Feb 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
GEOGRAPHIC REGIONS
We currently sell and distribute our Nu Skin business’s products in nearly 50 markets. We have divided these markets into seven segments: Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Our Rhyz business arm also includes two additional segments: Manufacturing and Rhyz Other. The following table sets forth the revenue for each of the segments and the Other category for the last three years.
| Year Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| (U.S. dollars in millions) · 2024 · 2023 · 2022 | ||||||
| Nu Skin | ||||||
| Americas | $322.5 | 19% | $398.2 | 20% | $508.5 | 23% |
| Southeast Asia/Pacific | 244.8 | 14 | 267.2 | 14 | 344.4 | 16 |
| Mainland China | 235.2 | 14 | 298.1 | 15 | 360.4 | 16 |
| Japan | 181.6 | 10 | 207.8 | 10 | 224.9 | 10 |
| Europe & Africa | 164.2 | 9 | 192.4 | 10 | 204.3 | 9 |
| South Korea | 163.7 | 9 | 236.1 | 12 | 268.7 | 12 |
| Hong Kong/Taiwan | 130.6 | 8 | 153.6 | 8 | 157.2 | 7 |
| Other | 2.9 | — | (0.9) | — | 4.0 | — |
| Total Nu Skin | 1,445.5 | 83 | 1,752.5 | 89 | 2,072.4 | 93 |
| Rhyz | ||||||
| Manufacturing | 201.4 | 12 | 181.4 | 9 | 149.5 | 7 |
| Rhyz Other | 85.2 | 5% | 35.2 | 2% | 3.8 | — |
| Total Rhyz | 286.6 | 17 | 216.6 | 11 | 153.3 | 7 |
| Total | $1,732.1 | 100% | $1,969.1 | 100% | $2,225.7 | 100% |
Additional comparative revenue and related financial information is presented in Note 16 to the consolidated financial statements contained in this report.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.